| Tag | Content |
|---|
EnhancerAtlas ID | HS104-02961 |
Organism | Homo sapiens |
Tissue/cell | HUVEC |
Coordinate | chr1:94100670-94102700 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxo1 | MA0480.1 | chr1:94102055-94102066 | TGCTGTTTACA | + | 6.14 | | Myog | MA0500.1 | chr1:94101820-94101831 | AACAGCTGCAG | + | 6.02 | | NFAT5 | MA0606.1 | chr1:94102200-94102210 | AATGGAAAAT | - | 6.02 | | NFATC1 | MA0624.1 | chr1:94102200-94102210 | AATGGAAAAT | - | 6.02 | | NFATC3 | MA0625.1 | chr1:94102200-94102210 | AATGGAAAAT | - | 6.02 | | Sox6 | MA0515.1 | chr1:94101362-94101372 | CCATTGTTTT | + | 6.02 | | Tcf12 | MA0521.1 | chr1:94101820-94101831 | AACAGCTGCAG | + | 6.62 | | YY1 | MA0095.2 | chr1:94101485-94101497 | GCAGCCATCTTG | - | 6.74 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_38536 | chr1:94100801-94102735 | HUVEC |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I093635 | chr1 | 94100986 | 94102692 |
|
Enhancer Sequence | CTCAGTGAGG TGGGAGGATC ACCCGAGACC AGAAGTTTGA GGTTACAGTG AGCTATGATT 60
GCACCACTGA ACTCCAGCCT GGGCAACAGA ATGAGACCCT GTTTCTTAAA AAAATAAGTA 120
AATAAAAGTC CATTCCTCTT TAAGGTTAAA TAATATGCCA TTATATGGGT GTACTACTTT 180
TTTCCAGTTG AAGGACTTTG GGGTTGTCTC CAGTTTTTGT TTTTGTCAAT TACGAATAAT 240
GTCACTATAA ACATGCATAT AGACTTTTAT ACGGACATGT GTTTTCATAA GGTTTTACTC 300
TTTATAAATG GCCACATTTT CATAGACCTG AAGGATAAGA TTCCACTGAA TGAGGGAGAC 360
TGTCATCCAT ACCTAGGATG TGGGAACATC CTACCTCAGC ATTTTTAATA ACTGTAGTAA 420
CACCGAACCT CCCAAGAATA TTTGCAGAGA ATGTTTTTGG GGTGGAGTGG AAGAAGTTGG 480
ATGGGAGCTC CCTTTCGTCC CTCTGCATGT GGGCCCCAGA GCGGGCCAGG GCTGTTTTAC 540
ATTCACTGCT GGCGGTGTTT GATCTCTGGT CCCACAGGGG ATGGCGCTGG CTCTGCCAAT 600
GTGCACACTC AGGCAAAAAC CTGCAGAGCC AGCCAATCGG CCCATTATTT GGTTCATATA 660
ACTTGTTAAA ATCTCATGGA ATGTACAGCG TGCCATTGTT TTTGTAAGTC CCTTTCATGG 720
CTTTGTGAGC TGGCTAATTC AGAGCAGACT GGCCTGCTTT CCTGCTGGAA GAAAAGGCTT 780
CTCTCAAAGA CAGCTATTTA ATTGTGACCA TGGCTGCAGC CATCTTGAGC ACAAAAAGGG 840
AGCTGAAGTC ACATCACCCC TTCTCCACTG AGGTCTCCGG CAGCCAGGGC ACTTATTCTT 900
GGCATTGGAA TTTGCATAAT TACTCCTTTT TAAATATGCT GGGTGACCTA ATATATCCCC 960
AGCCGGCTGC AGGAAATGGC CTTGCTGAGA TCTGAGCCTT GGATGGCCTG TAACGTCTAT 1020
AGACCTAGAA GACCCTTGGG GAAGGAGAAT TTTCAGAGCA TTGACCCCAG AAAGGACAGC 1080
TTCCTGAGTT TCTCTGGGGT CATCTGCACT GTGAAGGGAG AAGCTGCAGG GCTCTGTCCC 1140
CACTCAGGAT AACAGCTGCA GCCTTGTCCT TTCTTCTCCT AACCTGCGCA ACAAGCTCAG 1200
AGACTGTAGG TCATTCTATT ACAGCTCACA GTGGGTCTAA CAAGAACCCA CCAAGGCTGA 1260
CTACAAAAGA AAGAGGACAT GCGTTCACTA GGAATCTAGC CAGGAACAAA AGGTTGCATT 1320
CCGTCCTGAC ACTTCCTCAC TGCGGTAGCC TGGAGAGCAG GCCTTTGTCC ACAGGCGGGC 1380
AAGCGTGCTG TTTACAGCCT GGCCACAAAA AAACACTTGC CTATTCATGG CTAATTTGAA 1440
AAAAAAAAAC AAAAAAAACA GGCATTCCAA TATTTTTTTC TACTTCACCA TATTTTCTAA 1500
TGTAACTTTT TTGAGGACAA TTTATTTTAA AATGGAAAAT GTATAATAAA CACTTCTTCT 1560
AAAAGAAAAA TCACCCAGCC CTGCCCTAGC CAATCACTTC CTCCCTTAAA AAACTACAGC 1620
TTAAACCACC CCTAGAAAAG AACTCTTTAC TAAAATAACT GTAGGGCTGG TGTGTGAAGA 1680
GGCCAAAAAG AATTAGTCTT GGCCCAGCAT GGTGGCTCAT ATCTGTGATC CCAGCACTTC 1740
GGGAGGCTGA GGCAGGAGTA TCACTTGAGG CCAAGAGTTC GAGGCAAGCC TGGGCAACAT 1800
AGTGAGACCC TGTTTCTACA AAAAATAAAA AAAAATTAGG CATGGTGGTG GTCATCTGTG 1860
GTCCCAGTTA CCTGAGGGGG CTGAGGTGGG AGGATTGCTT GAGCCGAGGA GTTCAAAGCT 1920
TCAGTGAGCT ATGATCCTGC TACTGCACTC CAGCCTGGGC AACAGAGTAA GCCCCTGTCT 1980
CAAAAAACAA AACAAACAAA GCAGCACTAG TCTTGAGGCT AAAAGGAATA 2030
|
